berberine has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damiani, E; Donati, A; Orlando, F; Pierpaoli, E; Provinciali, M | 1 |
| Bartozzi, B; Damiani, E; Donati, A; Geroni, C; Lombardi, P; Lucarini, G; Orlando, F; Pierpaoli, E; Provinciali, M; Salvatore, C | 1 |
2 other study(ies) available for berberine and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Sidestream dark field videomicroscopy for in vivo evaluation of vascularization and perfusion of mammary tumours in HER2/neu transgenic mice.
Topics: Angiogenesis Inhibitors; Animals; Berberine; Female; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Microscopy, Video; Neovascularization, Pathologic; Rats; Receptor, ErbB-2 | 2015 |
Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Berberine; Berberine Alkaloids; beta-Galactosidase; Breast Neoplasms; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Neoplasm Proteins; Neovascularization, Pathologic; Receptor, ErbB-2 | 2015 |